Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study - Concepedia

Concepedia

Publication | Open Access

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

DOI Full Paper Access

28

Citations

12

References

2019

Year

Richard Gale, Ian Pearce, Nicole Eter, Faruque Ghanchi, Frank G. Holz, Steffen Schmitz-Valckenberg, Konstantinos Balaskas, Ben Burton, Susan M. Downes, Haralabos Eleftheriadis,

British Journal of Ophthalmology

Abstract

Switching from aflibercept to ranibizumab led to a significant improvement in CSRT, with ~60% experiencing stabilised/improved BCVA. Therefore, patients with nAMD who have shown a suboptimal response to aflibercept may benefit from switching to ranibizumab.

References

	Year	Citations

Page 1